TRICIA WILLIAMS: Open Payments
NPI 1528341187 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 50 payments from 16 companies in 2025. Trend: 2023 $1,008 · 2024 $1,050 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $161 |
| Ardelyx, Inc. | 6 | $126 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| Corcept Therapeutics | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $88 |
| Calliditas Therapeutics US Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Fresenius USA Marketing, Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $37 |
Products named: IBSRELA, Ozempic, JARDIANCE, JYNARQUE, Korlym, TARPEYO, VELPHORO, ACTHAR.
Industry payments across OH — which companies pay providers there.
